1. Home
  2. YSXT vs AVTX Comparison

YSXT vs AVTX Comparison

Compare YSXT & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YSXT
  • AVTX
  • Stock Information
  • Founded
  • YSXT 2011
  • AVTX 2011
  • Country
  • YSXT China
  • AVTX United States
  • Employees
  • YSXT N/A
  • AVTX N/A
  • Industry
  • YSXT Automotive Aftermarket
  • AVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • YSXT Consumer Discretionary
  • AVTX Health Care
  • Exchange
  • YSXT Nasdaq
  • AVTX Nasdaq
  • Market Cap
  • YSXT 58.6M
  • AVTX 248.3M
  • IPO Year
  • YSXT 2024
  • AVTX 2015
  • Fundamental
  • Price
  • YSXT $2.45
  • AVTX $17.76
  • Analyst Decision
  • YSXT
  • AVTX Strong Buy
  • Analyst Count
  • YSXT 0
  • AVTX 9
  • Target Price
  • YSXT N/A
  • AVTX $30.14
  • AVG Volume (30 Days)
  • YSXT 117.5K
  • AVTX 547.3K
  • Earning Date
  • YSXT 07-31-2025
  • AVTX 11-07-2025
  • Dividend Yield
  • YSXT N/A
  • AVTX N/A
  • EPS Growth
  • YSXT N/A
  • AVTX N/A
  • EPS
  • YSXT 0.18
  • AVTX N/A
  • Revenue
  • YSXT $71,452,736.00
  • AVTX $441,000.00
  • Revenue This Year
  • YSXT N/A
  • AVTX N/A
  • Revenue Next Year
  • YSXT N/A
  • AVTX N/A
  • P/E Ratio
  • YSXT $13.26
  • AVTX N/A
  • Revenue Growth
  • YSXT 22.04
  • AVTX N/A
  • 52 Week Low
  • YSXT $1.68
  • AVTX $3.39
  • 52 Week High
  • YSXT $9.96
  • AVTX $19.41
  • Technical
  • Relative Strength Index (RSI)
  • YSXT 46.53
  • AVTX 67.17
  • Support Level
  • YSXT $2.42
  • AVTX $15.58
  • Resistance Level
  • YSXT $2.68
  • AVTX $19.20
  • Average True Range (ATR)
  • YSXT 0.26
  • AVTX 1.58
  • MACD
  • YSXT 0.01
  • AVTX 0.25
  • Stochastic Oscillator
  • YSXT 53.62
  • AVTX 69.47

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: